• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 14, 2024
Product Development

Clinical Report: Acelyrin shifts priorities; Rivus moving forward in obesity

Plus: Readouts from Avidity, Apellis/Sobi, Levicept and Merck
Read More
BioCentury | Jan 7, 2023
Discovery & Translation

Autocrine signaling targets for fibrosis in NASH; plus a blood-based biomarker for Alzheimer’s and more

BioCentury’s roundup of translational news
Read More
BioCentury | Jun 2, 2017
Product Development

Ears wide open

How hearing loss became an investable space
Read More
BioCentury | Feb 15, 2017
Distillery Techniques

Drug delivery

Read More
BioCentury | Jan 11, 2016
Emerging Company Profile

Synaptic sound

How Decibel plans to amass a hearing loss portfolio
Read More
BioCentury | Nov 5, 2015
Distillery Therapeutics

Therapeutics: Neurotrophin 3 (NTF3)

Read More
BioCentury | Sep 15, 2014
Emerging Company Profile

Levicept: Modulating NGF

Levicept hopes NGF modulator may be disease modifying in osteoarthritis
Read More
BioCentury | May 8, 2014
Tools & Techniques

Zapping hearing loss

Read More
BioCentury | Mar 4, 2010
Distillery Therapeutics

Indication: Cancer

Read More
BioCentury | Feb 27, 2006
Product Development

Targeted =/ narrow

Read More
Items per page:
1 - 10 of 28